Key Quantitative Figures

  • Total Warrants Allotted: 77,02,182 (seventy-seven lakh two thousand one hundred and eighty-two)
  • Total Upfront Amount Received: ₹1,499,999,944.50 (Rupees One hundred forty-nine crore ninety-nine lakh ninety-nine thousand nine hundred forty-four rupees and fifty paise)
  • Issue Price per Warrant: ₹779
  • Face Value per Equity Share: ₹2
  • Conversion Ratio: 1 Warrant = 1 Equity Share
  • Conversion Period: 18 months from date of allotment (19 August 2026)
  • Balance Payment Pending: 75% of issue price, payable at conversion

Dates of Action

  • Board Approval Date: 13 June 2026 (initial approval)
  • EGM Date: 9 July 2026 (shareholder approval)
  • BSE In-principle Approval: Reference LOD/PREF/KS/FIP/633/2026-27
  • NSE In-principle Approval: Reference NSE/LIST/55834
  • Finance Committee Approval: 19 August 2026 at 18:45 hrs (IST) via circulation
  • Allotment Date: 19 August 2026
  • Filing Date: 20 August 2026

Parties Involved

Allottees (Promoter/Promoter Group):

1. Dr. Abhinay Bollineni (Promoter) - 32,09,242 warrants; ₹624,999,879.50 received

2. Mr. Adwik Bollineni (Promoter) - 32,09,242 warrants; ₹624,999,879.50 received

3. Bharas Ventures LLP (Promoter Group entity) - 12,83,698 warrants; ₹250,000,185.50 received

  • Entire capital contribution made by Dr. Bhaskara Rao Bollineni and Ms. Rajyasri Bollineni (both Promoters)

Company Officials:

  • Nagajayanthi J. R. - Company Secretary & Compliance Officer (signed the filing)
  • Sachin Ashok Salvi - Chief Financial Officer (signed the funds statement)

Regulators/Stock Exchanges:

  • BSE Limited
  • National Stock Exchange of India Limited
  • SEBI (ICDR Regulations compliance)

Auditors:

  • S. R. Batliboi & Associates LLP, Chartered Accountants (Firm Registration Number: 101049W/E300004)
  • Mitesh K Parikh, Partner (Membership Number: 225333)

Bank Account Details

  • Bank: Kotak Mahindra Bank Limited
  • Branch: 9-1-129/2 Oxford Plaza, Sarojini Devi Road, Secunderabad
  • Account Number: 3751153285
  • Account Name: KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED A/C

Capital Structure Impact

Current Status: No immediate change in paid-up equity share capital as only warrants have been allotted.

Post-Conversion Impact (if all warrants converted):

  • Dr. Abhinay Bollineni: Holding increases from 2,36,495 shares (0.06%) to 34,45,737 shares (0.81%)
  • Mr. Adwik Bollineni: Holding increases from 40,640 shares (0.01%) to 32,49,882 shares (0.76%)
  • Bharas Ventures LLP: Holding increases from Nil shares to 12,83,698 shares (0.30%)
  • Promoter & Promoter Group Combined: Holding increases from 32.50% to 33.71%

Note: Preferential issue shareholding percentages are based on the quarterly shareholding pattern for the quarter ended 30 June 2026.

Auditor's Certification

S. R. Batliboi & Associates LLP provided a limited assurance report dated 19 August 2026 confirming:

  • Receipt of 25% consideration from respective allottee bank accounts
  • Maintenance of relevant records as required by ICDR Regulations
  • The amount of ₹1,499,999,945 was received and credited to the specified bank account

Financial Impact

Immediate Impact: ₹149.99 crore received as 25% upfront payment (warrant subscription money).

Future Impact: Additional ₹449.99 crore expected upon conversion of warrants within 18 months.